IRIS
BIELLO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.839
AS - Asia 501
NA - Nord America 472
Continente sconosciuto - Info sul continente non disponibili 113
SA - Sud America 47
AF - Africa 9
Totale 3.981
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.764
US - Stati Uniti d'America 449
SG - Singapore 156
CN - Cina 108
BD - Bangladesh 98
VN - Vietnam 84
FR - Francia 29
BR - Brasile 26
HK - Hong Kong 22
AR - Argentina 9
DE - Germania 9
CA - Canada 7
FI - Finlandia 6
GB - Regno Unito 6
JP - Giappone 5
PH - Filippine 5
TR - Turchia 5
EC - Ecuador 4
ID - Indonesia 4
JM - Giamaica 4
MY - Malesia 4
NL - Olanda 4
UA - Ucraina 4
HN - Honduras 3
IN - India 3
PL - Polonia 3
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
IE - Irlanda 2
MX - Messico 2
PY - Paraguay 2
SE - Svezia 2
SV - El Salvador 2
UY - Uruguay 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
GT - Guatemala 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MU - Mauritius 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.868
Salva come PNG Salva come JPEG
Città #
Genoa 1.056
Genova 1.000
Rapallo 386
Vado Ligure 247
San Jose 82
Singapore 67
Ashburn 55
Lauterbourg 25
Hanoi 24
Ho Chi Minh City 23
Hong Kong 22
Beijing 21
New York 19
Council Bluffs 18
Buffalo 12
Los Angeles 10
St Louis 10
Santa Clara 9
Frankfurt am Main 8
Milan 8
Rome 8
Houston 7
Bordighera 6
Chicago 6
São Paulo 6
Helsinki 5
Atlanta 4
Naples 4
Princeton 4
Tokyo 4
Arlington 3
Billings 3
Biên Hòa 3
Cincinnati 3
Kingston 3
Orlando 3
Palermo 3
Resistencia 3
Toronto 3
Addis Ababa 2
Amsterdam 2
Ancona 2
Bay City 2
Brownsville 2
Brussels 2
Bình Dương 2
Cassopolis 2
Cerritos 2
City of London 2
Cleveland 2
Da Nang 2
Dallas 2
Davao City 2
Dhaka 2
Dublin 2
Fort Lauderdale 2
Guayaquil 2
Haiphong 2
Hefei 2
Hoover 2
Houma 2
Istanbul 2
Jacksonville 2
Johannesburg 2
Kyiv 2
Las Vegas 2
Leander 2
Lexington 2
Orem 2
Paris 2
Petaling Jaya 2
Philadelphia 2
Queens 2
Red Oak 2
San José 2
San Salvador 2
Santiago 2
Shenzhen 2
Spring Hill 2
Stockholm 2
Thái Nguyên 2
Tianjin 2
Turin 2
Vinh 2
Warsaw 2
Woodstock 2
Zurich 2
Aci Catena 1
Alexandria 1
Anna 1
Arapiraca 1
Artena 1
Asunción 1
Avezzano 1
Bacoor 1
Baghdad 1
Bakersfield 1
Baltimore 1
Bari 1
Barletta 1
Totale 3.292
Salva come PNG Salva come JPEG
Nome #
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 204
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 201
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 181
Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy 180
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 170
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 166
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study 163
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 162
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 154
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 148
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment 137
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer 137
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. 136
Afatinib for the treatment of non-small cell lung cancer 136
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 135
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine 135
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review 133
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 126
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 121
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer 116
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC 115
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 105
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy 105
Vinflunine for the treatment of non-small cell lung cancer 103
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review) 96
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer 93
Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy 88
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer 77
Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab 65
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 34
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity 32
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 20
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry 7
Totale 3.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.960
article - articoli 15.960
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022280 0 8 10 18 14 23 6 63 36 34 15 53
2022/2023431 27 36 8 39 75 68 0 43 65 5 61 4
2023/2024278 7 24 11 36 20 66 14 25 11 26 4 34
2024/2025684 35 41 17 56 77 69 59 156 24 38 62 50
2025/20261.326 172 20 72 93 170 64 179 50 116 138 122 130
2026/2027165 164 1 0 0 0 0 0 0 0 0 0 0
Totale 3.981